Rizatriptan (Rizamelt) dispersible tab 10 mg: Supply issue

Supply issue Active

Due to an increase in demand and delays at the factory, there is a supply issue affecting Rizamelt tablets (Pharmacode: 2394634).

Affected product

Due to an increase in demand and delays at the factory, the supplier has a limited supply of the following product:

  • Chemical: Rizatriptan 
  • Presentation: Tab orodispersible 10 mg
  • Brand: Rizamelt
  • Pharmacode: 2394634
  • Subsidy: $4.84
  • Measure / Qty: per 30

Alternative product

Unfortunately, due to the short timeframe of this supply issue, we have not been able to source a different brand of rizatriptan. 

Where Rizamelt is unavailable, people may want to talk to the person who prescribed their Rizamelt about whether another medicine will work for them. A new prescription will be needed.

Health care professionals

Other treatments for acute migraine are available. The NZ Formulary has more information about each option.

Treatment guidance for acute migraines | NZ Formulary(external link)

Supply issue flyer for pharmacists

Expected resupply end October 2025

The supplier expects the next shipment to arrive by late October 2025. It can take another 1 to 2 weeks for stock to reach pharmacies around New Zealand Aotearoa. 

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)